If you’re not familiar with Cancer Research then you may not know who Clay Siegall is. If you’re well in-tuned with Cancer Research then you definitely who this man is. Dr. Clay Siegall plays a critical role in the fight against this deadly disease known as cancer. He is the President, CEO, and Founder for one of the leading biotechnology organizations in the world. Seattle Genetics is that organization and it redefining cancer research by saving lives. Dr. Siegall has been in the industry for many decades and he has become well respected throughout the industry thanks to his extensive resume. The guy has literally worked with the biggest of names such as Bristol Myers Squibb, The National Institute of Health, and The National Cancer Institute. He has strong passion for he does and has built himself up into a living legend.
Seattle Genetic specializes in the development and commercialization of antibody based therapies. These therapies are far superior than it’s predecessors because of their capabilities. Antibody Drug Conjugates are the weapon of choice and this organization produces them very well. These medications deliver a cell killing shot of agents right into cancerous cells within the body without harming any good cells. Dr. Clay Siegall has entered these medications into multiple strategic licensed deals with GlaxoSmithKline, Genentech, and Pfizer. Now the powerful medications can be used in other countries, 65 countries worldwide to be exact. Hundreds of millions of dollars have been racked up in the U.S. and Canada alone and as of today, the medications have brought in around $325 Million. Thanks to Dr. Siegall’s brilliant way of thinking, he has forced the growth of Seattle Genetics by means of rigorous research, scientific innovation, and drug development. This is the blueprint of success that also happens to be Clay Siegall’s main principles.
Having written up to 70 publications, the current holder of 15 patents, and with the heart of gold, Dr. Clay Siegall has become a modern day living legend.